News and Information About Vioxx
VIOXX NEWS
Merck Previously Knew of Vioxx Heart Risks
NPR, December 5, 2005
4Article
Ruling May Hurt Merck in Federal Trial
Associated Press, November 28, 2005
4Article
First Federal Trial Over Merck's Vioxx to Begin
LA Times, November 28, 2005
4Article
For Merck, Second Vioxx Trial Off to Inauspicious Start
Miami Herald, September 18, 2005
4Article
We're All Patients Now
Alternet, September 14, 2005
4Article
Maker of Vioxx Says Some Suits Will be Settled
The New York Times, August 26, 2005
4Article
Hendlerlaw's Strategic Partner Wins Nation's First Vioxx Case
CNN, August 19th, 2005
4Article
Merck Face Big Vioxx Showdown in New Jersey
CNN, August 14, 2005
4Article
Texas, Merck Spar Over Vioxx Trial Site
Consumer Affairs, August 8, 2005
4Article
Marketing Team Targeted in Vioxx Trial
Forbes, July 19, 2005
4Article
Study Finds Doctors & Pharmacists Receive Limited Rx Training
USA Today, July 8, 2005
4Article
Merck Fails in Bid to Postpone Vioxx Trial
Boston Globe, July 6, 2005
4Article
Memo Shows Merck Knew Vioxx's Risk
Seattle Times, June 23, 2005
4Article
Researchers Had Doubts About Vioxx
AP, June 23, 2005
4Article
E-mails Suggest Merck May Have Known of Vioxx's Risks
The New York Times, May 21, 2005
4Article
How Merck Stacked The Vioxx Deck
Source: Salon.com March 31, 2005
4Article
Merck Canceled an Early Study of Vioxx
Source: The Ledger, February 8, 2005
4Article
Were Pain Pills Overprescribed?
Source: Chicago Sun-Times, January 24,2005
4Article
Vioxx, Celebrex Overprescribed?
Source: USA Today, January 23, 2005
4Article
Merck's Vioxx Ad Blitz Draws Fire
Source: The Street.com January 5, 2005
4Article
Scientist Raises Estimate of Vioxx Ill-effects
Source: Financial Times, January 2, 2005
4Article
Drug Warnings a Muddle to Arthritis Patients
Source: Pittsburgh Post Gazette, December 22, 2004
4Article
Vioxx: More Debate, More Data
Source: Forbes, December 30, 2004
4Article
Aleve Questions & Answers
Source: WebMD, December 21, 2004
4Article
OTHER DRUG NEWS
New NSAID floodgates open
The Sun Herald, June 23, 2005
4Article
Group Calls for Two Arthritis Drug Bans
Source: WebMD, January 26, 2005
4Article
Mixing Bextra, Aspirin May Up Blood Clot Risk
Source: WebMD, January 20, 2005
4Article
Drug risks raise doubt about ads
Source: The Christian Science Monitor, December 24, 2004
4Article
A Brief History of Celebrex and Bextra
Source: TheStreet.com, December 20, 2004
4Article
Aleve Questions & Answers
Source: WebMD, December 21, 2004
4Article
Bextra Label Updated With Warnings Concerning Severe Skin Reactions and Cardiovascular Risk
Source: PharmaLive.com, December 9, 2004
4Article
FDA NEWS
FDA launches Drug Alert Website
4Article
FDA Critic Seeks Revamp of Drug Safety Review
WebMD, March 10, 2005
4Article
What Ails the FDA? Payola
Boston Globe, March 10, 2005
4Article
FDA to Weigh Fate of Bextra, Celebrex, Similar Drugs
Source; Forbes, February 14, 2005
4Article
Celebrex Lessons
Boston Globe, February 6, 2005
4Article
Graham's Controversial Vioxx Study Published
Source: Sci-Tech Today, January 26, 2005
4Article
FDA Offers Advisory for Painkillers
Source: NPR, December 22, 2004
4Article
Why are potentially harmful drugs getting FDA approval?
Source: NBC News, December 18, 2004
4Article
Dealing in Death: Bush's FDA
Source: BaltimoreChronicle, December 17, 2004
4Article
New Worries About Drug Safety
Source: Forbes, December 16, 2004
4Article
|
